Atrial Fibrillation (AF)NCT06953752
Effects of Music During Atrial Fibrillation Ablation Under Conscious Sedation
A study testing Music intervention in people with Atrial Fibrillation (AF) and Catheter Ablation, run by Shaoxing People's Hospital at 1 site in China.
Trial summary
I. Background Atrial fibrillation, a common type of arrhythmia, is often treated with radiofrequency catheter ablation, a minimally invasive procedure that helps restore a normal heart rhythm. Read more about this study
- Who is it for?
- Ages 18 to 80 years
- Conditions the study is for
- Atrial Fibrillation (AF), Catheter Ablation, Pain Management
- What is being tested?
- Music intervention
- Type of treatment
- Injection or infusion
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 120 participants
- Where
- 1 siteChina
- Study dates
- 6 Jul 2025to 30 Dec 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 80 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Patients undergoing first-time catheter radiofrequency ablation for atrial fibrillation at our center according to guideline recommendations;
- Aged 18-80 years;
- Willing to participate in the study and providing signed informed consent.
Who cannot join
- Active psychiatric conditions necessitating pharmacotherapy;
- Auditory/cognitive barriers to protocol compliance;
- General anesthesia candidates;
- Hybrid AF procedures (e.g., concomitant LAA occlusion);
- Previous cardiac interventions;
- Complex anatomies per preprocedural imaging (e.g., persistent left superior vena cava, cor triatriatum);
- Recent (≤30 days) sedative/analgesic exposure."
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
China1 site, 1 recruiting
- Recruiting
Shaoxing People's Hospital
Shaoxing, Zhejiang, 312000
Buyun Xu, 15088681639, xbyzju@zju.edu.cn
About this study
Official title: Effects of Music on Pain and Anxiety During Atrial Fibrillation Ablation Under Conscious Sedation: A Randomized Controlled Trial
- Background Atrial fibrillation, a common type of arrhythmia, is often treated with radiofrequency catheter ablation, a minimally invasive procedure that helps restore a normal heart rhythm. While this surgery is typically performed under "light sedation" (where patients remain semi-awake) and allows for quick recovery, many patients still experience significant anxiety during the procedure due to pain, unfamiliar surroundings, or concerns about surgical risks. Research shows that anxiety not only makes people more sensitive to pain but can also trigger physical tension, irregular breathing, and even affect the precision of the surgeon's movements-potentially prolonging the procedure or increasing the risk of complications.
Currently, hospitals primarily rely on sedatives and painkillers to ease patient discomfort. However, these medications may cause side effects like low blood pressure or slowed breathing, which can be particularly dangerous for older patients with heart conditions. As a safer alternative, non-drug approaches like music therapy are gaining attention. Studies suggest that listening to music can reduce anxiety and pain in other medical settings (such as during biopsies or pre-surgery preparation), likely because it helps the body relax, reduces stress hormones, or distracts the mind. Yet, there's limited evidence on whether music can provide similar benefits during atrial fibrillation catheter ablation, especially in helping patients maintain steady breathing.
Read more
To address this gap, the present study aims to explore how music interventions affect anxiety, pain, and breathing stability in patients undergoing atrial fibrillation catheter ablation. Investigators hope this research will offer practical solutions to improve patient comfort, reduce reliance on medications, and enhance surgical safety, while also providing scientific support for expanding non-drug therapies in cardiac procedures.
II. Study Purpose To evaluate whether music during atrial fibrillation catheter ablation helps reduce patients' anxiety and pain, stabilize breathing, and improve satisfaction for both patients and doctors while making the procedure more efficient.
III. Study Design Prospective randomized controlled trial
IV. Study Plan
- Participants Inclusion Criteria:
- First-time atrial fibrillation ablation patients (aged 18-80) following clinical guidelines.
- Willing to participate and sign consent. Exclusion Criteria:
- Mental health issues (e.g., anxiety requiring medication, sleep disorders).
- Hearing loss, communication difficulties, or need for general anesthesia.
- Prior heart surgeries or catheter ablation, complex heart anatomy, or recent pain/sedation medication use. Grouping: Patients split evenly into "music group" or "control group," based on atrial fibrillation type (persistent or paroxysmal).
- Sample Size 60 patients/group (120 total) will be chosen.
- Blinding
- Patients and doctors know the group assignment (music or no music).
- Researchers assessing pain/anxiety and statisticians are blinded.
- Data Collected
- Basic info (age, weight, education).
- Health history (smoking, heart conditions, medications).
- Atrial fibrillation details (type, duration).
- Test results (e.g., heart size, kidney function).
- Pain/Sedation Protocol
- Light sedation with fentanyl (adjusted as needed).
- Extra midazolam given if heart rhythm needs electric correction.
- Ablation Procedure
- For Paroxysmal atrial fibrillation: Isolate lung veins.
- For Persistent atrial fibrillation: Extra ablation lines on heart walls.
- Power and pressure settings vary by heart area to balance safety and effectiveness.
- Music Intervention
- Music Group: Patients pick preferred music (classical, pop, etc.) played at 50-60 dB during procedure.
- Control Group:*No music.
- Outcomes Measured
Main Outcomes:
- Pain: Rated by patients post-surgery using a face-based scale.
- Anxiety: Measured before and after surgery with a standard questionnaire.
Secondary Outcomes:
- Breathing Stability: Breathing rate, pauses, and patterns.
- Procedure Efficiency: Surgery duration, X-ray time, success rate.
- Complications: Bleeding, heart injury, stroke risk.
- Drug Use: Amount of painkillers needed.
- Satisfaction: Ratings from patients and doctors (1-5 scale).
- Doctor Fatigue: Self-reported by surgeons.
- Conditions
- Atrial Fibrillation (AF), Catheter Ablation, Pain Management
- Being tested
- Music intervention, Control
- Medical subject headings
- Atrial Fibrillation, Agnosia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Music interventionOther
Music group patients select preferred genres (classical/pop/rock/jazz; classical default) delivered at 50-60 dB during the procedure.
ControlOther
Controls receive no music.
| Study group | Role | What they receive |
|---|---|---|
| Music intervention | Experimental | 1. Intraoperative Analgesia and Sedation Protocol:
The procedure is performed under conscious sedation using fentanyl (1 ug/kg loading dose post-transseptal puncture, then 1-2 ug/kg/h maintenance infusion titrated in 0.25 ug/kg/h increments). Midazolam 3-5 mg is administered for cardioversion with flumazenil reversal.
2. Ablation Protocol:
Ablation is performed using EnSite/CARTO systems. Paroxysmal AF patients receive bilateral pulmonary vein isolation ± trigger ablation; persistent AF patients receive additional posterior wall box ablation. Endpoints include bidirectional PVI (20-min observation) and roof line block. Posterior wall ablation is optional due to esophageal risk.
3. Music Intervention:
Music group patients select preferred genres (classical/pop/rock/jazz; classical default) delivered at 50-60 dB during the procedure. Receives: Other: Music intervention |
| Control | Other | 1. Intraoperative Analgesia and Sedation Protocol:
The procedure is performed under conscious sedation using fentanyl (1 ug/kg loading dose post-transseptal puncture, then 1-2 ug/kg/h maintenance infusion titrated in 0.25 ug/kg/h increments). Midazolam 3-5 mg is administered for cardioversion with flumazenil reversal.
2. Ablation Protocol:
Ablation is performed using EnSite/CARTO systems. Paroxysmal AF patients receive bilateral pulmonary vein isolation ± trigger ablation; persistent AF patients receive additional posterior wall box ablation. Endpoints include bidirectional PVI (20-min observation) and roof line block. Posterior wall ablation is optional due to esophageal risk.
3. Music Intervention:
Controls receive no music. Receives: Other: Control |
What is being measured
The primary outcome is the main question the study is designed to answer.
Wong-Baker FACES Pain Rating Scale Score
Postoperative pain assessment is performed immediately following the ablation procedure using the modified Wong-Baker FACES Pain Rating Scale (scored 0-10, where higher scores indicate greater pain intensity), with patients instructed to select the facial expression corresponding to their peak intraoperative pain experience.
Measured: Immediately following the ablation procedure
State-Trait Anxiety Inventory (STAI)
Anxiety levels are assessed using a shortened version of the original 20-item State-Trait Anxiety Inventory (the STAI-6, including three anxiety-present and anxiety-absent items, and each rated on a 4-point scale) at two time points: preoperatively (baseline) and immediately postoperatively (upon procedure completion).
Measured: Preoperatively (baseline) and immediately postoperatively (upon procedure completion)
Secondary outcomes (10)
Respiratory rate
Mean peak-to-peak interval of respiratory waveform.
Respiratory parameters are acquired through either:
- Built-in respiratory waveform of the 3D electroanatomical mapping system (e.g., EnSite™ or CARTO™), or
- Dedicated commercial respiratory monitoring devices (e.g., BioSignalPlux SOMNOtouch™ RESP), with signals synchronized to ablation timestamps.
Measured: During the procedure
Respiratory interval variability
Standard deviation(respiratory interval)/Mean(respiratory interval)×100%.
Respiratory parameters are acquired through either:
- Built-in respiratory waveform of the 3D electroanatomical mapping system (e.g., EnSite™ or CARTO™), or
- Dedicated commercial respiratory monitoring devices (e.g., BioSignalPlux SOMNOtouch™ RESP), with signals synchronized to ablation timestamps.
Measured: During the procedure
Amplitude variability of respiratory waveform
Standard deviation (respiratory waveform amplitude)/Mean(respiratory waveform amplitude)×100%.
Respiratory parameters are acquired through either:
- Built-in respiratory waveform of the 3D electroanatomical mapping system (e.g., EnSite™ or CARTO™), or
- Dedicated commercial respiratory monitoring devices (e.g., BioSignalPlux SOMNOtouch™ RESP), with signals synchronized to ablation timestamps.
Measured: During the procedure
Apnea episodes
Defined as ≥10-second cessation of breathing.
Respiratory parameters are acquired through either:
- Built-in respiratory waveform of the 3D electroanatomical mapping system (e.g., EnSite™ or CARTO™), or
- Dedicated commercial respiratory monitoring devices (e.g., BioSignalPlux SOMNOtouch™ RESP), with signals synchronized to ablation timestamps.
Measured: During the procedure
Sample entropy of respiratory waveform
Definition: A measure of respiratory signal complexity where: Lower values (0-1) indicate regular breathing patterns; Higher values (>1.5) reflect irregularity (e.g., pain-induced variability).
Calculation Steps:
- Preprocess Signal
- Sample respiratory waveform at ≥100 Hz;
- Bandpass filter (0.1-1 Hz) to remove artifacts;
- Normalize to SD=1.
- Set Parameters:
- Embedding dimension (*m*)=2 (standard for physiologic signals);
- Tolerance (*r*)=0.2×SD (typically 0.1-0.25);
- Time series length (N)=200-500 breaths.
- Algorithm:
- Construct template vectors: Xm(i)=[u(i),u(i+1),...,u(i+m-1)];
- Count vector pairs where Chebyshev distance ≤ *r*: B = matches for *m*-point vectors A = matches for (*m*+1)-point vectors;
- Compute:
Sample entropy =-ln(A/B).
Measured: During the procedure
Ablation time
Ablation time represents the sum of all radiofrequency application durations throughout the procedure, recorded in minutes
Measured: During the procedure
First-pass Left Pulmonary Vein Isolation (PVI) Rate
Defined as the proportion of left pulmonary veins achieving complete electrical isolation after initial circumferential ablation without touch-up lesions.
Measured: During the procedure
First-pass Right Pulmonary Vein Isolation (PVI) Rate
Defined as the proportion of Right pulmonary veins achieving complete electrical isolation after initial circumferential ablation without touch-up lesions.
Measured: During the procedure
Analgesic Dosage
Total intraoperative analgesic consumption is quantified as: Fentanyl equivalents (mcg/kg): Sum of bolus and maintenance doses
Measured: During the procedure
Rescue analgesia events
Number of supplemental dose administrations of analgesic drug.
Measured: During the procedure
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 May 2025
- Study start6 Jul 2025
- Primary completion30 Jun 2026 (estimated)
- Study completion30 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Atrial Fibrillation (AF)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 120 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Shaoxing People's Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Buyun Xu, Shaoxing People's Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06953752
- Sponsor's protocol ID
- IEC-K-AF-016-1.3
- Status last verified
- Apr 2025
- First submitted
- 21 Apr 2025
- Last updated
- 10 Jul 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 10 Jul 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of Music on Pain and Anxiety During Atrial Fibrillation Ablation Under Conscious Sedation: A Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT06953752
- Acronym / sponsor ID
- IEC-K-AF-016-1.3
- Conditions
- Atrial Fibrillation (AF), Catheter Ablation, Pain Management
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 120 participants (estimated)
- Lead sponsor
- Shaoxing People's HospitalUniversity, hospital or other
- Study start
- 6 Jul 2025 (actual)
- Primary completion
- 30 Jun 2026 (estimated)
- Study completion
- 30 Dec 2026 (estimated)
- First posted
- 1 May 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
- Background Atrial fibrillation, a common type of arrhythmia, is often treated with radiofrequency catheter ablation, a minimally invasive procedure that helps restore a normal heart rhythm. While this surgery is typically performed under "light sedation" (where patients remain semi-awake) and allows for quick recovery, many patients still experience significant anxiety during the procedure due to pain, unfamiliar surroundings, or concerns about surgical risks. Research shows that anxiety not only makes people more sensitive to pain but can also trigger physical tension, irregular breathing, and even affect the precision of the surgeon's movements-potentially prolonging the procedure or increasing the risk of complications.
Currently, hospitals primarily rely on sedatives and painkillers to ease patient discomfort. However, these medications may cause side effects like low blood pressure or slowed breathing, which can be particularly dangerous for older patients with heart conditions. As a safer alternative, non-drug approaches like music therapy are gaining attention. Studies suggest that listening to music can reduce anxiety and pain in other medical settings (such as during biopsies or pre-surgery preparation), likely because it helps the body relax, reduces stress hormones, or distracts the mind. Yet, there's limited evidence on whether music can provide similar benefits during atrial fibrillation catheter ablation, especially in helping patients maintain steady breathing.
To address this gap, the present study aims to explore how music interventions affect anxiety, pain, and breathing stability in patients undergoing atrial fibrillation catheter ablation. Investigators hope this research will offer practical solutions to improve patient comfort, reduce reliance on medications, and enhance surgical safety, while also providing scientific support for expanding non-drug therapies in cardiac procedures.
II. Study Purpose To evaluate whether music during atrial fibrillation catheter ablation helps reduce patients' anxiety and pain, stabilize breathing, and improve satisfaction for both patients and doctors while making the procedure more efficient.
III. Study Design Prospective randomized controlled trial
IV. Study Plan
- Participants Inclusion Criteria:
- First-time atrial fibrillation ablation patients (aged 18-80) following clinical guidelines.
- Willing to participate and sign consent. Exclusion Criteria:
- Mental health issues (e.g., anxiety requiring medication, sleep disorders).
- Hearing loss, communication difficulties, or need for general anesthesia.
- Prior heart surgeries or catheter ablation, complex heart anatomy, or recent pain/sedation medication use. Grouping: Patients split evenly into "music group" or "control group," based on atrial fibrillation type (persistent or paroxysmal).
- Sample Size 60 patients/group (120 total) will be chosen.
- Blinding
- Patients and doctors know the group assignment (music or no music).
- Researchers assessing pain/anxiety and statisticians are blinded.
- Data Collected
- Basic info (age, weight, education).
- Health history (smoking, heart conditions, medications).
- Atrial fibrillation details (type, duration).
- Test results (e.g., heart size, kidney function).
- Pain/Sedation Protocol
- Light sedation with fentanyl (adjusted as needed).
- Extra midazolam given if heart rhythm needs electric correction.
- Ablation Procedure
- For Paroxysmal atrial fibrillation: Isolate lung veins.
- For Persistent atrial fibrillation: Extra ablation lines on heart walls.
- Power and pressure settings vary by heart area to balance safety and effectiveness.
- Music Intervention
- Music Group: Patients pick preferred music (classical, pop, etc.) played at 50-60 dB during procedure.
- Control Group:*No music.
- Outcomes Measured
Main Outcomes:
- Pain: Rated by patients post-surgery using a face-based scale.
- Anxiety: Measured before and after surgery with a standard questionnaire.
Secondary Outcomes:
- Breathing Stability: Breathing rate, pauses, and patterns.
- Procedure Efficiency: Surgery duration, X-ray time, success rate.
- Complications: Bleeding, heart injury, stroke risk.
- Drug Use: Amount of painkillers needed.
- Satisfaction: Ratings from patients and doctors (1-5 scale).
- Doctor Fatigue: Self-reported by surgeons.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Music intervention | Experimental | Other: Music intervention1. Intraoperative Analgesia and Sedation Protocol: The procedure is performed under conscious sedation using fentanyl (1 ug/kg loading dose post-transseptal puncture, then 1-2 ug/kg/h maintenance infusion titrated in 0.25 ug/kg/h increments). Midazolam 3-5 mg is administered for cardioversion with flumazenil reversal. 2. Ablation Protocol: Ablation is performed using EnSite/CARTO systems. Paroxysmal AF patients receive bilateral pulmonary vein isolation ± trigger ablation; persistent AF patients receive additional posterior wall box ablation. Endpoints include bidirectional PVI (20-min observation) and roof line block. Posterior wall ablation is optional due to esophageal risk. 3. Music Intervention: Music group patients select preferred genres (classical/pop/rock/jazz; classical default) delivered at 50-60 dB during the procedure. |
| Control | Other | Other: Control1. Intraoperative Analgesia and Sedation Protocol: The procedure is performed under conscious sedation using fentanyl (1 ug/kg loading dose post-transseptal puncture, then 1-2 ug/kg/h maintenance infusion titrated in 0.25 ug/kg/h increments). Midazolam 3-5 mg is administered for cardioversion with flumazenil reversal. 2. Ablation Protocol: Ablation is performed using EnSite/CARTO systems. Paroxysmal AF patients receive bilateral pulmonary vein isolation ± trigger ablation; persistent AF patients receive additional posterior wall box ablation. Endpoints include bidirectional PVI (20-min observation) and roof line block. Posterior wall ablation is optional due to esophageal risk. 3. Music Intervention: Controls receive no music. |
Who may qualify
- Ages
- 18 to 80 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Patients undergoing first-time catheter radiofrequency ablation for atrial fibrillation at our center according to guideline recommendations;
- Aged 18-80 years;
- Willing to participate in the study and providing signed informed consent.
Key exclusion criteria (7 listed)
- Active psychiatric conditions necessitating pharmacotherapy;
- Auditory/cognitive barriers to protocol compliance;
- General anesthesia candidates;
- Hybrid AF procedures (e.g., concomitant LAA occlusion);
- Previous cardiac interventions;
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Music interventionMusic group patients select preferred genres (classical/pop/rock/jazz; classical default) delivered at 50-60 dB during the procedure. | Other | Music intervention |
| ControlControls receive no music. | Other | Control |
Primary outcome
Wong-Baker FACES Pain Rating Scale Score
Time frame: Immediately following the ablation procedure
Postoperative pain assessment is performed immediately following the ablation procedure using the modified Wong-Baker FACES Pain Rating Scale (scored 0-10, where higher scores indicate greater pain intensity), with patients instructed to select the facial expression corresponding to their peak intraoperative pain experience.
State-Trait Anxiety Inventory (STAI)
Time frame: Preoperatively (baseline) and immediately postoperatively (upon procedure completion)
Anxiety levels are assessed using a shortened version of the original 20-item State-Trait Anxiety Inventory (the STAI-6, including three anxiety-present and anxiety-absent items, and each rated on a 4-point scale) at two time points: preoperatively (baseline) and immediately postoperatively (upon procedure completion).
10 secondary outcomes
Respiratory rate
Time frame: During the procedure
Respiratory interval variability
Time frame: During the procedure
Amplitude variability of respiratory waveform
Time frame: During the procedure
Apnea episodes
Time frame: During the procedure
Sample entropy of respiratory waveform
Time frame: During the procedure
Ablation time
Time frame: During the procedure
First-pass Left Pulmonary Vein Isolation (PVI) Rate
Time frame: During the procedure
First-pass Right Pulmonary Vein Isolation (PVI) Rate
Time frame: During the procedure
Analgesic Dosage
Time frame: During the procedure
Rescue analgesia events
Time frame: During the procedure
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 10 Jul 2025.
Related trials for Atrial Fibrillation (AF)
Active, not recruiting
Horizon 360 Protocol for the Treatment of Paroxysmal Atrial Fibrillation With the Sphere-360™ Catheter and Affera™ Mapping and Ablation System (Horizon 360)
Paroxysmal AF
Active, not recruiting
CONVERGE Post-Approval Study (PAS)
Chronic Atrial Fibrillation
RecruitingPhase 2
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
Atrial Fibrillation (AF)
RecruitingPhase 3
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
Atrial Fibrillation (AF)
Not yet recruitingObservational study
Hummingbird ICE Study
ATRIAL APPENDAGE CLOSURE for ATRIAL FIBRILLATION, Atrial Fibrillation (AF)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Music intervention in people with Atrial Fibrillation (AF) and Catheter Ablation, run by Shaoxing People's Hospital at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 10 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Wong-Baker FACES Pain Rating Scale Score (time frame: Immediately following the ablation procedure). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jul 2025.